These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12522911)

  • 21. Biological and chemical agents: a brief synopsis.
    Rosenbloom M; Leikin JB; Vogel SN; Chaudry ZA
    Am J Ther; 2002; 9(1):5-14. PubMed ID: 11782813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioterriorism: from threat to reality.
    Atlas RM
    Annu Rev Microbiol; 2002; 56():167-85. PubMed ID: 12142472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tularemia ("rabbit plague")].
    Hassler D; Schwarz TF; Braun R
    Dtsch Med Wochenschr; 2003 Jan; 128(3):70. PubMed ID: 12596770
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA; Broussard LA
    Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plague and tularemia.
    Butler T
    Pediatr Clin North Am; 1979 May; 26(2):355-66. PubMed ID: 379779
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-lasting T cell responses to biological warfare vaccines in human vaccinees.
    Allen JS; Skowera A; Rubin GJ; Wessely S; Peakman M
    Clin Infect Dis; 2006 Jul; 43(1):1-7. PubMed ID: 16758411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioterrorism.
    Steinhauer R
    RN; 2002 Mar; 65(3):48-54; quiz 55. PubMed ID: 11961869
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monitoring of life-threatening infection pathogens in relation to the problem of prediction of critical situations].
    Staritsyn NA; Marinin LI; Pomerantsev AP; Stepanov AV; Veriasova GV; Urakov NN
    Vestn Ross Akad Med Nauk; 1999; (12):3-6. PubMed ID: 10709458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anthrax as a biological weapon].
    Makino S
    Shokuhin Eiseigaku Zasshi; 2002 Jun; 43(3):J228-32. PubMed ID: 12238162
    [No Abstract]   [Full Text] [Related]  

  • 30. Particulate delivery systems for biodefense subunit vaccines.
    Bramwell VW; Eyles JE; Oya Alpar H
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1247-65. PubMed ID: 15935873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiology of biological weapons--old and the new?
    Ketai L; Tchoyoson Lim CC
    Semin Roentgenol; 2007 Jan; 42(1):49-59. PubMed ID: 17174174
    [No Abstract]   [Full Text] [Related]  

  • 32. Community-acquired pneumonia in the age of bio-terrorism.
    Dattwyler RJ
    Allergy Asthma Proc; 2005; 26(3):191-4. PubMed ID: 16119032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of anthrax as biological weapon].
    Rizzo G
    Ann Ig; 2004; 16(4):603-12. PubMed ID: 15366519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparing for biological threats: Addressing the needs of pregnant women.
    Watson AK; Ellington S; Nelson C; Treadwell T; Jamieson DJ; Meaney-Delman DM
    Birth Defects Res; 2017 Mar; 109(5):391-398. PubMed ID: 28398677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparing for bioterrorism: category A agents.
    Persell DJ; Arangie P; Young C; Stokes EN; Payne WC; Skorga P; Gilbert-Palmer D
    Nurse Pract; 2001 Dec; 26(12):12-5, 19-24, 27; quiz 28-9. PubMed ID: 11809039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological agents as weapons 2: anthrax and plague.
    Whitby M; Ruff TA; Street AC; Fenner FJ
    Med J Aust; 2002 Jun; 176(12):605-8. PubMed ID: 12064962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plague].
    Durst R; Robenshtok E; Sagi R
    Harefuah; 2002 May; 141 Spec No():84-7, 120. PubMed ID: 12170561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathobiology and management of laboratory rodents administered CDC category A agents.
    He Y; Rush HG; Liepman RS; Xiang Z; Colby LA
    Comp Med; 2007 Feb; 57(1):18-32. PubMed ID: 17348288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioterrorism: class A agents and their potential presentations in immunocompromised patients.
    Richard JL; Grimes DE
    Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical management of potential bioterrorism-related conditions.
    Adalja AA; Toner E; Inglesby TV
    N Engl J Med; 2015 Mar; 372(10):954-62. PubMed ID: 25738671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.